We’re more than six months into 2025 already—can you believe it?

It’s been a busy year for healthcare news, from looming tariffs to DOGE cuts. But there have also been some big deals around the industry since Jan. 1.

Healthcare Brew wanted to break down the largest mergers, acquisitions, and buyouts so far this year. We worked with global market data research company PitchBook and reviewed public notices to create a list of the biggest deals in the US as of June 4.

PitchBook collects information by tracking control acquisitions and leveraged buyouts, including asset acquisitions, corporate divestitures, corporate asset purchases, spinoffs, and asset divestitures. Final deal values represent the total amount of equity and debt used in the transaction.

See all the year’s biggest deals so far here.—CM

When it comes to scientific achievements that have advanced the practice of medicine, you’d be hard-pressed to find one more influential than the Human Genome Project.

The project, a federally funded collaboration between scientists around the globe, began in October 1990 with the goal of improving our knowledge of human biology by sequencing an entire human genome, which is the complete set of DNA in a cell.

Nearly 13 years and $2.7 billion later, the project wrapped up in April 2003, and scientists around the world now use the reference human genome to study genetics, biology, and more. Today, the entire human genome can be sequenced in as little as five hours and costs as little as $600.

Learn more about the Human Genome Project’s impact here.—MA